AbbVie, Gubra post obesity data; Regeneron obesity drug succeeds in China
AbbVie, Gubra post obesity data; Regeneron obesity drug succeeds in China
Contenu indisponible. Consultez la source originale.
AbbVie, Gubra post obesity data; Regeneron obesity drug succeeds in China
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.